PG
PTLA

Pendal Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Pendal Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,747
Closed -$323K – 501
2017
Q2 		$323K Buy
+5,747
New +$323K ﹤0.01% 392